|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G16B 20/00 |
| (11) | Patento numeris | 3639172 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18735154.9 |
| Europos patento paraiškos padavimo data | 2018-06-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-04-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-03-31 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2018/037008 |
| Data | 2018-06-12 |
| (87) | Numeris | WO 2018/231762 |
| Data | 2018-12-20 |
| (30) | Numeris | Data | Šalis |
| 201762518787 P | 2017-06-13 | US | |
| 201762598440 P | 2017-12-13 | US |
| (72) |
BAGAEV, Alexander, RU
FRENKEL, Feliks, RU
ATAULLAKHANOV, Ravshan, RU
|
| (73) |
BostonGene Corporation,
95 Sawyer Road, Suite 500, Waltham, MA 02453,
US
|
| (54) | SYSTEMS AND METHODS FOR IDENTIFYING CANCER TREATMENTS FROM NORMALIZED BIOMARKER SCORES |
| SYSTEMS AND METHODS FOR IDENTIFYING CANCER TREATMENTS FROM NORMALIZED BIOMARKER SCORES |